A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries
- Focus Therapeutic Use
- Sponsors C3J Therapeutics
- 14 Jun 2017 Status changed from active, no longer recruiting to completed.
- 21 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Feb 2017 New trial record